Inicio › Enfermedad de Crohn › Florida
Ensayos clínicos de Enfermedad de Crohn en Florida
27 estudios sobre Enfermedad de Crohn buscan participantes en Florida.
Ciudades en Florida
- Miami19 estudios
- Orlando17 estudios
- Tampa10 estudios
- Kendall5 estudios
- Jacksonville4 estudios
- Hialeah4 estudios
- Spring Hill4 estudios
- Gainesville3 estudios
- Pensacola3 estudios
- Town 'n' Country3 estudios
- Clearwater3 estudios
- Lakeland3 estudios
Texto oficial del estudio (inglés)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- Covenant Metabolic Specialists, LLC ( Site 5150), Fort Myers
- Nature Coast Clinical Research - Inverness ( Site 5042), Inverness
- Sanchez Clinical Research ( Site 5144), Miami
- y 4 más
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 2 oct 2026 · NCT06430801Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Synergy Healthcare - Bradenton - 17th Avenue West /ID# 284157, Bradenton
- Clinical Research of Osceola /ID# 280593, Kissimmee
- Florida Center For Gastroenterology - Largo /ID# 281059, Largo
- y 3 más
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 2 oct 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Access Research Institute, Brooksville
- Gastro Florida, Clearwater
- Digestive and Liver Center of Florida, P.A., Kissimmee
- y 5 más
ReclutandoFase 4
Edades de 18 a 80 · Todos los sexos · Actualizado el 30 sept 2026 · NCT06581328Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Novum Research /ID# 278128, Clermont
- University of Florida College of Medicine /ID# 266930, Gainesville
- Nature Coast Clinical Research - Inverness /ID# 265874, Inverness
- y 9 más
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06548542A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Green Leaf Clinical Trials, Jacksonville
- Sanchez Clinical Research, Inc, Miami
- Biodax Medical Research Trials, Miami
- y 2 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- American Institute of Research, Cutler Bay
- Nature Coast Clinical Research, Inverness
- Florida Research Center Inc., Lakewood Rch
- y 2 más
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 sept 2026 · NCT07196722A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- West Central Gastroenterology, LLP, d/b/a/ Gastro Florida, Clearwater
- Auzmer Research, Lakeland
- Wellness Clinical Research, Miami Lakes
- y 3 más
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 25 sept 2026 · NCT06233461Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
- Orlando Health, Orlando
- y 3 más
ReclutandoFase 3
Edades de 18 a 70 · Todos los sexos · Actualizado el 24 sept 2026 · NCT06937099Tailored Anti-Inflammatory American Diet for Patients With Crohn's Disease
- University of Miami, Miami
Reclutando
Edades de 16 a 75 · Todos los sexos · Actualizado el 24 sept 2026 · NCT07671872An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Novum Research, LLC-Site Number: 8400003, Clermont
- Sarkis Clinical Trials - Gainesville-Site Number: 8400048, Gainesville
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee
- y 12 más
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 23 sept 2026 · NCT07184931A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee
- Columbus Clinical Services LLc-Site Number: 8400038, Miami
- Bioresearch Partner-Kendale Lakes-Site Number: 8400053, Miami
- y 2 más
ReclutandoFase 3
Edades de 16 a 80 · Todos los sexos · Actualizado el 23 sept 2026 · NCT07184944A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Arnold Palmer Hospital for Children Center Digestive Health and Nutrition-Orland /ID# 255437, Orlando
ReclutandoFase 3
Edades de 2 a 17 · Todos los sexos · Actualizado el 23 sept 2026 · NCT05995353A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Clinical Research of Osceola, Kissimmee
- Bioresearch Partner-Kendale Lakes, Miami
- Endoscopic Research Inc, Orlando
- y 1 más
ReclutandoFase 2
Edades de 18 a 85 · Todos los sexos · Actualizado el 22 sept 2026 · NCT06226883A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Gastro Health Research - Miami, Miami
- Ezy Medical Research, Miami Lakes
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07483073A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- Gastro Health Research - Miami, Miami
- Ezy Medical Research, Miami Lakes
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 22 sept 2026 · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- Clinical Research of Osceola, Kissimmee
- Endoscopic Research Inc, Orlando
- Alliance Clinical Research of Tampa, LLC, Tampa
ReclutandoFase 4
Edades de 18 a 70 · Todos los sexos · Actualizado el 9 sept 2026 · NCT06045754A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
- Florida Research Center Inc., Lakewood Rch
- Sanchez Clinical Research, Inc, Miami
- GCP Clinical Research, Tampa
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 28 ago 2026 · NCT07577843Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Mayo Clinic Jacksonville, Jacksonville
- Advent Health, Orlando
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 ago 2026 · NCT05230173Zymfentra (Infliximab-dyyb) REal World Cohort STudy
- University of Miami, Miami
- AdventHealth, Orlando
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 5 ago 2026 · NCT07237516Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
- Digestive & Liver Center of Florida, Orlando
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 jul 2026 · NCT06997965Precise Infliximab Exposure and Pharmacodynamic Control
- Nemours Children's Health System-Jacksonville, Jacksonville
ReclutandoFase 2/3
Edades de 6 a 22 · Todos los sexos · Actualizado el 5 may 2026 · NCT05660746Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
- Clinical Research Of Brandon, LLC, Brandon
- West Central Gastroenterology d/b/a Gastro Florida, Clearwater
- Auzmer Research, Lakeland
- y 7 más
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 abr 2026 · NCT06456593Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
- University of Miami, Miami
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 mar 2026 · NCT06774079A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400017, Kissimmee
- Investigational Site Number: 8400015, Lighthouse PT
- Investigational Site Number 8400028, Miami
- y 3 más
ReclutandoFase 2
Edades de 18 a 75 · Todos los sexos · Actualizado el 27 mar 2026 · NCT06958536A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Miami
- Mirador Therapeutics Selected Site, Miami
- Mirador Therapeutics Selected Site, Miami
- y 3 más
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 12 mar 2026 · NCT07113522A Pilot Study to Assess the Safety, Tolerability, and Efficacy of Virtual Reality for the Treatment of Abdominal Pain in Quiescent Crohn's Disease
- Mayo Clinic Florida, Jacksonville
Reclutando
Edades de 18 a 70 · Todos los sexos · Actualizado el 17 feb 2026 · NCT06647615Treatment of Moderate to Severe Refractory Crohn's Disease
- University of Florida, Gainesville
ReclutandoFase 1/2
Edades de 18 a 65 · Todos los sexos · Actualizado el 10 dic 2025 · NCT06721962De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.